Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Medicare
The Trump Administration Has Had an Active Few Weeks in the Drug Pricing…
The Administration has been quite active recently in the drug pricing space. It has been a top story in the health policy world…
CMS Issues Proposed Rule Focused on Part D and MA Drug Prices
On Monday, the Centers for Medicare and Medicaid Services (CMS) announced a proposed rule and opened comments that attempts to…
Law Passed to Crack Down on Chinese Fentanyl Traffickers
On October 24, 2018, the SUPPORT for Patients and Communities Act became law after passing both the House and the Senate with…
CMS Posts 2019 Physician Fee Schedule includes changes to Medicare Part B…
On November 1, 2018, the Centers for Medicare & Medicaid Services (CMS) finalized its 2019 Medicare Physician Fee Schedule. We…
CMS Submits Part D and Medicare Advantage Drug Pricing Proposal to Office…
We previously wrote about the proposed rule released by the United States Centers for Medicare and Medicaid Services (CMS) for…
CMS Releases Proposed CY20 Medicare Advantage/Part D Rule
Recently, the Centers for Medicare & Medicaid Services (CMS) released their Contract Year (CY) 2020 Medicare Advantage and…
HHS Unveils New Plan for Prescription Prices for Medicare Part B Drugs
On Thursday, October 25, 2018, the United States Department of Health and Human Services (HHS) and the Centers for Medicare &…
CMS Adds Option of Step Therapy for Medicare Plans
On August 7, 2018, the Centers for Medicare & Medicaid Services (CMS) announced it will provide Medicare Advantage plans the…
CMS Instituting Changes to Medicare Part D Formulary Coverage
On August 29, 2018, the Centers for Medicare and Medicaid Services (CMS) issued a memo to Medicare Part D plans, outlining new…
Medicare Part D Premiums Continue to Decline
On July 31, 2018, the United States Centers for Medicare & Medicaid Services announced that for the second year in a row, the…